While antibiotics given in the first week of life reduce vaccine responses at 15 months, probiotics might counteract these ...

Agencies call for sustained investments in immunization efforts amidst looming funding cuts.Geneva/New York, 24 April 2025 - Immunization efforts are under growing threat as misinformation, population ...

Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).

The U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has ...

Coherent Market Insights published a report, titled, the global meningococcal vaccines market size is estimated to grow from ...

A panel of federal health experts recommended expanded vaccine options for several diseases, including RSV, meningitis, and chikungunya.

GSK’s 5-in-1 meningococcal vaccine Penmenvy receives positive recommendation from US Advisory Committee on Immunization Practices: London, UK Saturday, April 19, 2025, 13:00 Hrs ...

The U.S. CDC's Advisory Committee recommends the use of GSK's pentavalent Penmenvy vaccine as part of the adolescent ...

A federal panel of experts on Wednesday recommended an expansion of RSV vaccinations for adults and a new combination shot as ...

Meningococcal disease is a severe, fast-progressing infection; vaccination is key for high-risk groups, preventing life-threatening complications like sepsis, brain damage, or death. Read on to know ...

A conjugate meningococcal vaccine (Menactra) was licensed in the U.S. in January 2005 and is recommended for all 11- and 12-year-olds, students entering high school, and college freshmen dormitory ...

US Health and Human Services Secretary Robert F. Kennedy Jr. publicly urged people to get the measles vaccine in an interview with CBS News on Tuesday. “We encourage people to get the measles ...